City

Hangzhou (1)

Munchen (1)

Pozzilli (1)

Condition

Epilepsy, Rolandic (4)

BECTS (1)

Overall Status

Completed (2)

Terminated (1)

Unknown status (1)

Sign in for free

Phase

phase 3 (1)

phase 4 (1)

Sponsor

Janssen Korea, Ltd., Korea (1)

Ludwig-Maximilians - University of Munich (1)

Neuromed IRCCS (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

Collaborator

Intervention

ids;mmspe;cdi 2;cbcl;tests of facial expression evaluation (1)

topamax (1)

treatment with levetiracetam or sulthiame over a six-month period. (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (2)

Observational (2)

epilepsy, rolandic

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Processing Speed Dysfunction and Brain Functional Abnormality in

Completed

Epilepsy, Rolandic

Hangzhou, Zhejiang, China

Department of Nuclear Medicine and PET/CT Center, The Second Aff

Jul 6, 2021

Emotion Recognition in Benign Epilepsy of Childhood With

Unknown status

BECTS
Epilepsy, Rolandic

IDS;MMSPE;CDI 2;CBCL;tests of facial expression evaluation

Pozzilli, Isernia, Italy

IRCCS Neuromed

Oct 31, 2018

Epilepsy, Rolandic Trial (topamax)

Completed

Epilepsy, Rolandic

topamax

(no location specified)

Jan 31, 2011

Epilepsy, Rolandic Trial in München (Treatment with levetiracetam or sulthiame over a six-month period.)

Terminated

Epilepsy, Rolandic

Treatment with levetiracetam or sulthiame over a six-month period.

München, Germany

Dr. von Haunersches Kinderspital

Jan 28, 2009